HPV-16/18 L1 VLP AS04 vaccine (GSK-580299)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV-16/18 L1 VLP AS04 vaccine (GSK-580299), covering 2015-05-08 to 2015-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old [Phase 3]